PortfoliosLab logoPortfoliosLab logo
AVPT vs. ZVRA
Performance
Return for Risk
Drawdowns
Volatility
Dividends
Financials

Performance

AVPT vs. ZVRA - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in AvePoint, Inc. (AVPT) and Zevra Therapeutics Inc. (ZVRA). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, AVPT achieves a -18.72% return, which is significantly lower than ZVRA's 21.43% return.


AVPT

1D
-2.00%
1M
10.58%
YTD
-18.72%
6M
-11.66%
1Y
-39.98%
3Y*
18.94%
5Y*
10Y*

ZVRA

1D
-5.31%
1M
8.04%
YTD
21.43%
6M
33.17%
1Y
25.64%
3Y*
29.24%
5Y*
-0.40%
10Y*
-20.83%
*Multi-year figures are annualized to reflect compound growth (CAGR)

AVPT vs. ZVRA - Yearly Performance Comparison


2026 (YTD)20252024202320222021
AVPT
AvePoint, Inc.
-18.72%-15.87%101.10%99.76%-34.66%-47.36%
ZVRA
Zevra Therapeutics Inc.
21.43%7.43%27.33%42.70%-47.30%-32.74%

Correlation

The correlation between AVPT and ZVRA is 0.16, which is low. Their price movements are largely independent, making them effective diversification partners.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

0.16

Correlation (3Y)
Calculated over the trailing 3-year period

0.20

Correlation (All Time)
Calculated using the full available price history since Jul 6, 2021

0.25

Fundamentals

Market Cap

AVPT:

$2.55B

ZVRA:

$655.31M

EPS

AVPT:

$0.20

ZVRA:

$2.16

PE Ratio

AVPT:

55.68

ZVRA:

5.03

PS Ratio

AVPT:

5.85

ZVRA:

5.11

PB Ratio

AVPT:

5.82

ZVRA:

3.18

Total Revenue (TTM)

AVPT:

$443.68M

ZVRA:

$122.29M

Gross Profit (TTM)

AVPT:

$326.90M

ZVRA:

$104.94M

EBITDA (TTM)

AVPT:

$53.29M

ZVRA:

$149.15M

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

AVPT vs. ZVRA — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

AVPT
AVPT Risk / Return Rank: 1010
Overall Rank
AVPT Sharpe Ratio Rank: 77
Sharpe Ratio Rank
AVPT Sortino Ratio Rank: 99
Sortino Ratio Rank
AVPT Omega Ratio Rank: 99
Omega Ratio Rank
AVPT Calmar Ratio Rank: 1313
Calmar Ratio Rank
AVPT Martin Ratio Rank: 1414
Martin Ratio Rank

ZVRA
ZVRA Risk / Return Rank: 5454
Overall Rank
ZVRA Sharpe Ratio Rank: 5555
Sharpe Ratio Rank
ZVRA Sortino Ratio Rank: 5555
Sortino Ratio Rank
ZVRA Omega Ratio Rank: 5454
Omega Ratio Rank
ZVRA Calmar Ratio Rank: 5454
Calmar Ratio Rank
ZVRA Martin Ratio Rank: 5252
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

AVPT vs. ZVRA - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for AvePoint, Inc. (AVPT) and Zevra Therapeutics Inc. (ZVRA). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


AVPTZVRADifference

Sharpe ratio

Return per unit of total volatility

-0.89

0.43

-1.32

Sortino ratio

Return per unit of downside risk

-1.11

1.05

-2.16

Omega ratio

Gain probability vs. loss probability

0.85

1.13

-0.28

Calmar ratio

Return relative to maximum drawdown

-0.73

0.63

-1.36

Martin ratio

Return relative to average drawdown

-1.17

1.10

-2.27

AVPT vs. ZVRA - Sharpe Ratio Comparison

The current AVPT Sharpe Ratio is -0.89, which is lower than the ZVRA Sharpe Ratio of 0.43. The chart below compares the historical Sharpe Ratios of AVPT and ZVRA, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Sharpe Ratios by Period


AVPTZVRADifference

Sharpe Ratio (1Y)

Calculated over the trailing 1-year period

-0.89

0.43

-1.32

Sharpe Ratio (5Y)

Calculated over the trailing 5-year period

-0.01

Sharpe Ratio (10Y)

Calculated over the trailing 10-year period

-0.26

Sharpe Ratio (All Time)

Calculated using the full available price history

-0.02

-0.27

+0.25

Drawdowns

AVPT vs. ZVRA - Drawdown Comparison

The maximum AVPT drawdown since its inception was -69.96%, smaller than the maximum ZVRA drawdown of -99.27%. Use the drawdown chart below to compare losses from any high point for AVPT and ZVRA.


Loading charts...

Drawdown Indicators


AVPTZVRADifference

Max Drawdown

Largest peak-to-trough decline

-69.96%

-99.27%

+29.31%

Max Drawdown (1Y)

Largest decline over 1 year

-54.04%

-43.47%

-10.57%

Max Drawdown (3Y)

Largest decline over 3 years

-55.03%

-43.47%

-11.56%

Max Drawdown (5Y)

Largest decline over 5 years

-74.01%

Max Drawdown (10Y)

Largest decline over 10 years

-97.85%

Current Drawdown

Current decline from peak

-43.52%

-97.12%

+53.60%

Average Drawdown

Average peak-to-trough decline

-36.04%

-86.38%

+50.34%

Ulcer Index

Depth and duration of drawdowns from previous peaks

33.73%

24.81%

+8.92%

Volatility

AVPT vs. ZVRA - Volatility Comparison

AvePoint, Inc. (AVPT) has a higher volatility of 18.42% compared to Zevra Therapeutics Inc. (ZVRA) at 17.46%. This indicates that AVPT's price experiences larger fluctuations and is considered to be riskier than ZVRA based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


AVPTZVRADifference

Volatility (1M)

Calculated over the trailing 1-month period

18.42%

17.46%

+0.96%

Volatility (6M)

Calculated over the trailing 6-month period

31.67%

36.15%

-4.48%

Volatility (1Y)

Calculated over the trailing 1-year period

45.22%

59.83%

-14.61%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

46.89%

60.17%

-13.28%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

46.89%

81.33%

-34.44%

Dividends

AVPT vs. ZVRA - Dividend Comparison

Neither AVPT nor ZVRA has paid dividends to shareholders.


Tickers have no history of dividend payments

Financials

AVPT vs. ZVRA - Financials Comparison

This section allows you to compare key financial metrics between AvePoint, Inc. and Zevra Therapeutics Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


0.0020.00M40.00M60.00M80.00M100.00M120.00M20222023202420252026
117.24M
36.22M
(AVPT) Total Revenue
(ZVRA) Total Revenue
Values in USD except per share items

Frequently Asked Questions


AVPT and ZVRA have a correlation of 0.16, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

AVPT has higher volatility (18.42%) compared to ZVRA (17.46%). In terms of maximum drawdown, AVPT dropped -69.96% vs ZVRA's -99.27%.

ZVRA currently has the higher Sharpe Ratio (0.43 vs -0.89), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for AVPT and ZVRA

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer